Search - tctmd.com

$TCT-50. Influence of Age on Clinical Outcomes in Patients with NSTEMI Undergoing Treatment with Abciximab plus Unfractionated Heparin vs. Bivalirudin: Analysis of the ISAR...$

Presentation TCT 2012

TCT-50. Influence of Age on Clinical Outcomes in Patients with NSTEMI Undergoing Treatment with Abciximab plus Unfractionated Heparin vs. Bivalirudin: Analysis of the ISAR...

Presenter: Lamin King

October 23, 2012

Presentation TCT 2012

Radial Approach for NSTEMI: Case Closed or Worth Changing Practice?

Presenter: Robert Applegate

October 23, 2012

News Daily News

Urgent Invasive Strategy Key for Out-of-Hospital Arrest Patients with ACS

Jason Kahn

October 23, 2012

News Industry News

New Retrospective Studies of Hospital Readmission Rates for Subsequent Heart Attack and Initial Hospitalization Costs in ACS-PCI Patients Treated with Effient® (Prasugrel) or Plavix® (Clopidogrel) Pre

October 23, 2012

Advertisement

El Análisis Anual del Reino Unido sobre el Uso de PCI Identifica cómo Evolucionan los Patrones

Subestudio PLATO: La Ventaja del Ticagrelor Persiste tras el 1er Episodio Isquémico

PLATO Substudy: Ticagrelor Advantage Persists After First Ischemic Event

TCTMD’s Top 10 Most Popular News Stories for 2012

Las Noticias Más Leídas del “Top 10” de TCTMD en 2012

Case Report: Use of OrbusNeich’s Genous™ Stent with Bivalirudin for Acute Coronary Syndrome Patients at Risk for Bleeding Due to Hematological Cancer

Italian Generic Clopidogrel Worse Than Brand Name at Suppressing Platelets

El Genérico Italiano Clopidogrel es Peor que la Marca Comercial en la Supresión Plaquetaria

Una Estancia Hospitalaria Más Larga se asocia a una Atención Menos Empríca tras un cuadro de NSTEMI

Longer Hospital Stay Linked with Less Evidence-Based Care in NSTEMI

Hospital Length of Stay in Patients with NSTEMI

No Mortality Benefit with Prolonged Dual Antiplatelet Therapy

TRILOGY ACS Substudy: No Relationship Between Platelet Reactivity, Outcomes

TRILOGY ACS Substudy: Angiography Prior to Prasugrel Therapy Reduces CV Events

Tailored Clopidogrel Therapy Bests Prasugrel at Control of Platelet Reactivity in ACS

Study Finds That Prasugrel May Reduce Cardiovascular Events Among Patients Managed Medically After an Angiogram for Acute Coronary Syndrome

TCT-50. Influence of Age on Clinical Outcomes in Patients with NSTEMI Undergoing Treatment with Abciximab plus Unfractionated Heparin vs. Bivalirudin: Analysis of the ISAR...

Radial Approach for NSTEMI: Case Closed or Worth Changing Practice?

Urgent Invasive Strategy Key for Out-of-Hospital Arrest Patients with ACS

New Retrospective Studies of Hospital Readmission Rates for Subsequent Heart Attack and Initial Hospitalization Costs in ACS-PCI Patients Treated with Effient® (Prasugrel) or Plavix® (Clopidogrel) Pre

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content